Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia.
López-Novoa
José M
JM
Departamento de Fisiología y Farmacología, Edificio Departamental, Campus Miguel de Unamuno, 37007 Salamanca, Spain. jmlnovoa@usal.es
D000818:Animals; D015703:Antigens, CD / Q000097:blood* / Q000235:genetics; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D018450:Disease Progression; D000071063:Endoglin; D005260:Female; D015870:Gene Expression; D006801:Humans; D010641:Phenotype; D010920:Placenta / Q000378:metabolism; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism; D011247:Pregnancy; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics; D011956:Receptors, Cell Surface / Q000097:blood* / Q000235:genetics; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000097:blood / Q000235:genetics
D015703:Antigens, CD; D015415:Biomarkers; C064206:ENG protein, human; D000071063:Endoglin; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; C501162:FLT1 protein, human; D040281:Vascular Endothelial Growth Factor Receptor-1